Your browser doesn't support javascript.
loading
Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications.
Fritsche, Andreas; Heni, Martin; Peter, Andreas; Gallwitz, Baptist; Kellerer, Monika; Birkenfeld, Andreas L; Häring, Hans-Ulrich; Wagner, Robert.
Afiliação
  • Fritsche A; German Center for Diabetes Research (DZD), Neuherberg.
  • Heni M; Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University Tübingen, Tübingen.
  • Peter A; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen.
  • Gallwitz B; German Center for Diabetes Research (DZD), Neuherberg.
  • Kellerer M; Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University Tübingen, Tübingen.
  • Birkenfeld AL; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen.
  • Häring HU; German Center for Diabetes Research (DZD), Neuherberg.
  • Wagner R; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen.
Exp Clin Endocrinol Diabetes ; 130(3): 200-204, 2022 Mar.
Article em En | MEDLINE | ID: mdl-32947641

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Jejum / Diabetes Mellitus Tipo 2 Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Jejum / Diabetes Mellitus Tipo 2 Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article